3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
17
Ovarian Neoplasms
11
Neoplasms
8
Fallopian Tube Neoplasms
8
Triple Negative Breast Neoplasms
7
Prostatic Neoplasms
6
Neoplasm Metastasis
6
Pancreatic Neoplasms
4
Endometrial Neoplasms
4
Neuroendocrine Tumors
3
Glioma
3
Glioblastoma
3
Carcinoma, Ovarian Epithelial
3
Recurrence
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Fanconi Anemia, Complementation Group D1
2
Cholangiocarcinoma
2
Uveal Melanoma
1
Urogenital Neoplasms
1
Solid Tumors
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
SCLC,Extensive Stage
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Platinum-sensitive Ovarian Cancer
1
Interventions
Magnetic Resonance Spectroscopy
23
Radiosurgery
21
Temozolomide
14
Bevacizumab
12
pembrolizumab
10
Specimen Handling
9
Nivolumab
8
Radiotherapy
7
Ipilimumab
7
Magnetic Resonance Imaging
6
Cyclophosphamide
5
Capecitabine
5
Blood Specimen Collection
5
encorafenib
4
Radiation
4
Neuropsychological Tests
4
Mental Status and Dementia Tests
4
Memantine
4
Carboplatin
4
fludarabine
3
fluciclovine F-18
3
binimetinib
3
abemaciclib
3
Watchful Waiting
3
Proton Therapy
3
Etoposide
3
Dexamethasone
3
Adrenal Cortex Hormones
3
trastuzumab deruxtecan
2
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Brain Neoplasms
×
olaparib
×
Clear all
NCT04711824
2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2
Recruiting
41 enrolled